About CPF
Company Profiles
Awards
Global Collaboration
Media Center
Subsidiary
Products & Services
API and intermediates
Dosage
Services
R&D
News
Company News
Industry News
Contact Us
中
About CPF
Products & Services
R&D
News
Contact Us
API and intermediates
Dosage
Services
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No.
API
CAS No.
Indication
21
Folic Acid
59-30-3
Vitamin
22
Hydrochlorothiazide
58-93-5
Diuretics
23
LCZ696(Sacubitril + Valsartan)
936623-90-4
Heart failure
24
Ledipasvir Actone /PVP
1256388-51-8
HCV
25
Lenalidomide
191732-72-6
Oncology drug
26
Niraparib
1038915-60-4
Ovarian/Fallopian,tube/primary peritoneal cancer
27
Obeticholic Acid
459789-99-2
Biliary cholangitis
28
Pitavastatin Calcium
147526-32-7
Hypercholesterolemia
29
Pregabalin
148553-50-8
Epilepsy/Neuralgia
30
Pregabalin Capsules
50mg/75mg/100mg/150mg/200mg/225mg/300mg
Epilepsy/Neuralgia
31
Relugolix
737789-87-6
Antineoplastic
32
Ribociclib
1374639-75-4
HR-positive, HER2-negative Andvance ormetastaticbreast Cancers
33
Rimegepant
1289023-67-1
Migraine headache
34
Rivaroxaban
366789-02-8
Anticoagulant
35
Rosuvastatin Calcium
147098-20-2
Hypercholesterolemia
36
Rosuvastatin Calcium Tablets
5mg/10mg/20mg/40mg
Hypercholesterolemia
37
Ruxolitinib
941678-49-5
Myelofibrosis
38
Sacubitril Hemicalcium
1369773-39-6
Heart failure
39
Sofosbuvir
1190307-88-0
HCV
40
Sugammadex Sodium
343306-79-6
Neuromuscular blockade
1
2
3
Leave Your Message
SAND OUT